Preface.
1. Antibody Engineering - Optimizing the Delivery Vehicle (Diane
Milenic).
2. The Radiochemistry of Monoclonal Antibodies and Peptides (Raymond
M. Reilly).
3. The Design of Radiolabeled Peptides for Targeting Malignancies (Leonard
G. Luyt).
4. Peptide Receptor Radionuclide Therapy in Patients with Somatostatin
Receptor-Positive Neuroendocrine Tumors (Martijn van Essen, Dik J.
Kwekkeboom, Wouter W. de Herder, Lisa Bodei, Boen L.R. Kam, Marion de
Jong, Roelf Valkema and Eric P. Krenning).
5. Targeted Radiotherapy of CNS Malignancies (Michael R. Zalutsky,
David A. Reardon and Darrell D. Bigner).
6. Radioimmunotherapy for B-Cell Non-Hodgkin Lymphoma (Thomas E.
Witzig).
7. Radioimmunotherapy of Acute Myeloid Leukemia (Todd L. Rosenblat
and Joseph G. Jurcic).
8. Pre-Targeted Radioimmunotherapy of Solid Tumors (Robert M. Sharkey
and David G. Goldenberg).
9. Targeted Auger Electron Radiotherapy of Malignancies (Raymond M.
Reilly and Amin Kassis).
10. Viral Introduction of Receptors for Targeted Radiotherapy (Kathryn
Ottolino-Perry and J. Andrea McCart).
11. Preclinical Cell and Tumor Models for Evaluating
Radio-Pharmaceuticals in Oncology (Ann F. Chambers, Eva A. Turley,
John Lewis and Leonard G. Luyt).
12. Radiation Biology of Targeted Radiotherapy (David Murray and
Michael Weinfeld).
13. Dosimetry for Targeted Radiotherapy (Sui Shen).
14. The Bystander Effect in Targeted Radiotherapy (Carmel Mothersill
and Colin Seymour).
15. The Role of Molecular Imaging in Evaluating Tumor Response to
Targeted Radiotherapy (Norbert Avril).
16. The Economic Attractiveness of Targeted Radiotherapy - Value for
Money (Jeffrey S. Hoch).
17. Selected Regulatory Elements in the Development of Cancer Targeted
Protein and Peptide Radiotherapeutic Agents (Thomas R. Sykes and
Connie J. Sykes).
Index.
Author Information:
RAYMOND M. REILLY is a
Professor in the Leslie Dan Faculty of Pharmacy at the University of
Toronto. He has more than twenty years of experience in the field of
radiolabeled antibody and peptide targeting of cancer. Dr. Reilly has
written over 180 publications in the field, including more than 100
scientific papers on radiopharmaceuticals for cancer imaging and
targeted radiotherapy.